B U S I N E S S | Saturday, August 28, 1999 |
|
weatherspotlight today's calendar |
Amway makes no tall
claims: CEO M and M, Mitsubishi patch up |
|
D S group forays into food and
beverages NPPA hikes price of asthma
medicine |
||||||||
Amway
makes no tall claims: CEO CHANDIGARH, Aug 27 Amway India, a leading direct selling company, is opening its office in Chandigarhs Sector 26 tomorrow. In the very first year of its operations ending this August, Amway has clocked a Rs 100 crore turnover 75 per cent of it coming from product sales and the remaining 25 per cent from non-product sales. With Punjab emerging as the top contributor to sales, the company is shortly opening its offices in Ludhiana, Jalandhar and Amritsar. Direct selling is a new business concept about which many have apprehensions. Amway India CEO Sudershan Banerjee in an interview with Business Tribune sheds light on some dark corners of the business. Excerpts: Q. Why do direct selling companies make tall promises and often hire novice sellers instead of professionals for selling their products. Amway does not make any tall claims. Distributors do sometimes. We let the products do the talking. As for the second part of the question, anyone can become a distributor. He or she should fulfil two conditions. One, the candidate should be above 18 and secondly, be alive. Each distributor is charged Rs 4,200 as entry fee and an annual renewal fee of Rs 595. Q. Your products are quite expensive. A toothpaste costs Rs 99, a detergent Rs 550. Why should anyone buy your products? Going by cost per use, our products are actually cheaper. They come in concentrated form in large containers. That is why they appear costlier. We are planning to introduce smaller bottles and even sachets. A car wash bottle priced at Rs 200 costs Rs 2 per wash. Our toothpaste lasts twice longer than its rivals in the market. Q. Will you explain the concept of direct selling and how does Amway practise it? Direct selling is an alternative form of product distribution. It allows sellers to build a business through their own sales efforts and by inviting others to become sellers. Remuneration is based on a sellers personal sales and on the combined sales of those they have sponsored, trained and motivated. A customer has the option to buy products at his own convenience. Amway has a unique money refund scheme under which 70 per cent cost of a product is refunded if a customer is not satisfied. A distributor can exit the business any time and his initial payment will be repaid after necessary adjustments. Each earns according to his ability and efforts. Its like a university. We provide training and an opportunity to do business. Q. Why dont you create assets, invest in real estate? It appears the company can disappear anytime. We do not invest in real
estate. But we have offices in various parts of the
country with satellite links. We have invested $ 35
million in the country. Of this $ 4 million has been
spent on providing technology and processes to our
contract manufacturers in Pune, Hyderabad and Daman. We
invest in training our distributors. Amway has a presence
in 80 countries and a network of three million
distributors. |
Lupin Labs net dips 26 per cent Lupin Laboratories Ltd has reported a 26 per cent fall in net profits at Rs 25.30 crore for the year ended June 30, 1999 as against Rs 34.24 crore in the previous year. The company has, however, maintained the dividend at 25 per cent. Indias third largest company has recorded a turnover of Rs 715.73 crore during 1998-99 compared to Rs 695.10 crore last year. The reduction in profits was partly due to trading policy correction in the domestic formulations market in the second half of the accounting year and conscious control of exports to CIS countries and China as also increase in costs led by expansion of domestic field force, Lupin Group Chairman, Desh Bandhu Gupta said in a statement here today. Higher interest costs at Rs 51.58 crore this year were on account of debt financing of its investments in the USA, he said. The companys depreciations costs were also up at Rs 11.92 crore. The other group company, Lupin Chemicals has posted a 14 per cent rise in net profits to Rs 12.49 crore during the year on a turnover of Rs 110.38 crore as against Rs 109.21 crore last year. Lupin Chemicals has declared a dividend of 10 per cent for the year 1998-99. Turnover and profits would have been higher but for a one-month shut down at the plant for schedule maintenance and synchronisation of the new five MW captive power plant, he said Essar Power Ltd, has posted a 117 per cent rise in its net profit at 39 crore during the financial year ended March 31, 1999 as against the previous years Rs 18 crore. The turnover for 1998-99 was Rs 723 crore from last years Rs 410 crore. The company, in a release said that the growth in turnover as well as net profit has been achieved despite the companys plant at Hazira being affected during the period under review by the natural calamities like cyclones in the June, 1998 floods in Gujarat during September, 1998. The 515 MW power plant had a plant load factor (PLF) of 71 per cent for 1998-99. UTI has objected to some of the provisions of the modified draft rehabilitation scheme for reviving sick Nirlon Ltd, including sale of companys property in Mumbai. Objections raised by UTI include sale of two floors of Nirlon House at Mumbai, composition of sale committee for properties and right of recompense in respect of sacrifices under the one time settlement (OTS). The company owes Rs 32.36 crore to UTI. The Board for Industrial and Financial Reconstruction, had earlier this year circulated a rehabilitation scheme of Rs 78.48 crore for the company which included OTS of Rs 50.02 crore with various financial institutions including UTI. Kinetic Fincap, engaged in two wheeler financing has recorded a net profit of Rs 30.38 lakh in the first quarter (May to July) of the current fiscal as against Rs 22.5 lakh in the corresponding period in the previous fiscal. The Kinetic group companys income rose by 20 per cent to Rs 9.64 crore from Rs 8.00 crore in the first quarter of 1998-99, it said in a statement here today. Kinetic Fincaps asset base had crossed the Rs 200 crore mark and was expected to grow further since scooter finance had picked up, companys Managing Director Ms Sulajja Firodia Motwani told the companys board yesterday. Tata Tea Limited, will set up a new subsidiary in Europe to acquire major shareholding and management control in the UK based Tetley Limited. Tata Tea sources said
here today that the company will invest around £ 75
million for purchasing shares of the new subsidiary.
Agencies |
D S group
forays into food and beverages NEW DELHI, Aug 27 The Rs 400 crore D S group today announced its foray into the food and beverages sector with the launch of Catch Natural Spring Water. A separate arm of the group, D S Foods Limited, has been established for the food and beverages sector. Over the next few months, the company plans to introduce a wide range of products including ice, tea, club soda, flavoured water and edible oil. The group, which already has the established Catch brands of salts and spices, plans to invest over Rs 100 crore in the next three years and will work towards achieving a 5 to 10 per cent market share. The company has already set up two state-of-the-art production facilities. The Noida plant in Uttar Pradesh will be dedicated for the production of a range of food products, while the plant at Kulu in Himachal set up with an investment of Rs 11 crore will be produce bottled spring water. Unlike the currently available mineral water in India, Catch Natural Spring Water is one of the first brands to bottle pure spring water from the Himalayas without subjecting it to chemical treatment, the Director of D.S. Foods Limited, Mr R.N. Goel, said. The product will be
available in four different sizes 300 ml, 500 ml,
1 litre and 1.5 litres and priced Rs 12, Rs 15, Rs
25 and Rs 30, respectively. |
NPPA hikes price of asthma medicine NEW DELHI, Aug 27 (PTI) The National Pharmaceutical Pricing Authority (NPPA) has revised the prices of 16 drug formulations including Ventorlin Syrup used for the treatment of asthma and antibiotic Tetracycline. Out of the 16 formulations, the authority increased the prices of three drugs in the range between 13.90 per cent to 15.80 per cent and revised the prices downwards up to 46.98 per cent, an official release said here today. The NPPA has also fixed ceiling prices of some vitamin tablets and capsules as per the Drugs and Cosmetics Act, 1940 and with the provision of a price adjustment formula. With the ceiling price fixation, the prices of vitamins such as Beccosole-Z capsule, Sprovit, Zin Forte, Becozine cap, NVM tablet, Vitazinc cap, Zicomplex cap and Pro-Z will come down. The prices of Tetracycline HCI coated tab, manufactured by Hoechst Marion Roussel Ltd, has been revised downwards by 45 per cent to Rs 5.78 (a strip of ten) from Rs 10.52. The prices of capsules of vitamin B complex has been lowered by 42.28 per cent from Rs 15.80 to Rs 9.12. However, the authority
increased the prices of Ventrolin Syrup produced by
Kemwell Pvt Ltd by 13.9 per cent to Rs 8.44 from Rs 7.41. |
H |
| Nation
| Punjab | Haryana | Himachal Pradesh | Jammu & Kashmir | | Chandigarh | Editorial | Sport | | Mailbag | Spotlight | World | 50 years of Independence | Weather | | Search | Subscribe | Archive | Suggestion | Home | E-mail | |